Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Long-Term Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis: Results of SWITCH, a First-in-Human Study
Cerebrovascular Disease and Interventional Neurology
ES1 - Emerging Science (11:54 AM-12:00 PM)
005

The MNP provides direct communication between the brain and an external device by recording and decoding signals from the precentral gyrus as the result of movement intention. To date, implantation of MNPs has required surgery involving removal of a portion of the skull and placement of electrodes on the brain. A recently developed minimally invasive MNP reaches the brain by vascular access, without need for a craniotomy.

To assess safety of an endovascular motor neuroprosthesis (MNP) and feasibility of using the implant to control a computer by thought.

Subjects with paralysis were implanted with the endovascular device (Stentrode, Synchron, Brooklyn, NY) using a catheter to guide placement in the superior sagittal sinus. The device was attached to an electronics unit in a subcutaneous pocket to relay brain signals from the motor cortex into commands for a laptop computer. Safety endpoints were device-related serious adverse events resulting in death or increased disability during the 12-month post-implant evaluation period, and target vessel patency and incidence of device migration at 3 and 12 months. The study also recorded signal fidelity and stability over 12 months and use of the brain-computer interface to perform routine digital tasks.

The study enrolled five subjects with amyotrophic lateral sclerosis; four had suitable anatomy and underwent the implant procedure. All four subjects successfully completed the 12-month follow-up with no serious adverse events. Post-operative imaging demonstrated patent blood vessels in all subjects and no device migration. All subjects learned to use the MNP with eye tracking for routine computer use. The decoder developed during the study allowed the final participant to control a computer independently without an eye tracker.

In a first-in-human study, four subjects were implanted with an endovascular brain-computer interface. The study met its safety endpoints, allowing subjects with paralysis to operate a computer for daily tasks.

Authors/Disclosures
Bruce Campbell, MD, FAAN (Royal Melbourne Hospital, University of Melbourne)
PRESENTER
Dr. Campbell has nothing to disclose.

PRESENTER
No disclosure on file
Chiu Mun Sarah Lee, MD (Calvary Bethlehem Hospital) Dr. Lee has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Edward Karst Edward Karst has received personal compensation for serving as an employee of Synchron. Edward Karst has received personal compensation for serving as an employee of Abbott.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Anna H. Balabanski, MBBS (Department of Neurology, The Royal Melbourne Hospital) Dr. Balabanski has received research support from National Health and Medical Research (NHMRC) of Australia. Dr. Balabanski has received personal compensation in the range of $0-$499 for serving as a Guest Speaker with The Australian Stroke Academy.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Terence J. O'Brien, MD (The Alfred Hospital) The institution of Prof. O'Brien has received research support from Eisai. The institution of Prof. O'Brien has received research support from UCB. The institution of Prof. O'Brien has received research support from BioGen. The institution of Prof. O'Brien has received research support from ES Theraputics. The institution of an immediate family member of Prof. O'Brien has received research support from Epidarex.
J Mocco No disclosure on file
No disclosure on file
No disclosure on file
Thomas Oxley, MD No disclosure on file